Valla D, Pessegueiro-Miranda H, Degott C, Lebrec D, Rueff B, Benhamou J P
Service d'Hépatologie, (INSERM U 24), Hôpital Beaujon, Clichy, France.
Q J Med. 1987 Jun;63(242):531-44.
We have reviewed the clinical, histological and hemodynamic features of sarcoidosis complicated by portal hypertension in seven patients and in 40 previously reported cases. Young black patients of either sex and white females over 40 years were selectively affected. In 12 of these 47 patients, portal hypertension appeared to be a consequence of cirrhosis due to longstanding intrahepatic cholestasis; in white patients, this condition was clinically, histologically, and serologically indistinguishable from primary biliary cirrhosis. In most of the other patients, portal hypertension was the predominant and often the presenting symptom of hepatic sarcoidosis; in these patients portal hypertension was due to a presinusoidal block probably determined by portal granulomas, with or without superimposed sinusoidal block determined by fibrosis. Corticosteroids did not prevent the development of portal hypertension.
我们回顾了7例结节病合并门静脉高压患者以及40例既往报道病例的临床、组织学和血流动力学特征。年轻的黑人患者(无论性别)以及40岁以上的白人女性为选择性受累对象。在这47例患者中,有12例门静脉高压似乎是长期肝内胆汁淤积所致肝硬化的结果;在白人患者中,这种情况在临床、组织学和血清学上与原发性胆汁性肝硬化无法区分。在其他大多数患者中,门静脉高压是肝结节病的主要症状,且常常是首发症状;在这些患者中,门静脉高压是由门静脉肉芽肿可能导致的窦性前阻塞引起的,伴有或不伴有由纤维化导致的叠加窦性阻塞。皮质类固醇并不能阻止门静脉高压的发展。